Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450963) titled 'Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT' on Feb. 24.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Ruijin Hospital

Condition: Locally Advanced Cervical Cancer

Intervention: Drug: Cadonilimab

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: March 2026

Target Sample Size: 45

To know more, visit https://clinicaltrials.gov/study/NCT07450963

Published by HT Digital Content Services with permission from Health Daily Digest....